To the full analysis
Wangsu Science & Technology stock: growth
300017.SZWangsu Science & Technology reported $698.95M in revenue for fiscal 2025, down 5.5% on the prior year, down 3.9% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
24.8%
per year from 2006 to 2025, per share 24.8%
Earnings (Annual rate)
22.8%
per year from 2006 to 2025, per share 21.6%
Free cash flow (Annual rate)
29.5%
per year from 2006 to 2025, per share 29.5%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | −3.9% | 4.7% | 24.8% |
| Revenue per share | −4.2% | 3.1% | 24.8% |
| Earnings | 29.4% | −0.4% | 22.8% |
| Earnings per share | 29.4% | −1.9% | 21.6% |
| Free cash flow | 16.5% | 9.3% | 29.5% |
| Free cash flow per share | 16.2% | 7.6% | 29.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $10.35M | $2.44M | $908.54K |
| 2007 | $17.89M | $3.82M | $118.22K |
| 2008 | $35.85M | $5.56M | −$2.59M |
| 2009 | $41.75M | $5.83M | $674.48K |
| 2010 | $54.33M | $5.74M | −$5.64M |
| 2011 | $81.3M | $8.21M | $4.91M |
| 2012 | $122.19M | $15.56M | $18.93M |
| 2013 | $180.71M | $35.56M | $19.46M |
| 2014 | $286.55M | $72.54M | $56.24M |
| 2015 | $439.64M | $124.67M | $50.71M |
| 2016 | $666.82M | $187.51M | $6.3M |
| 2017 | $805.71M | $124.53M | −$52.2M |
| 2018 | $950.39M | $120.59M | −$105.28M |
| 2019 | $900.91M | $5.17M | −$28.93M |
| 2020 | $852.79M | $32.99M | $57.39M |
| 2021 | $686.09M | $24.78M | $87.08M |
| 2022 | $762.45M | $28.58M | $111.43M |
| 2023 | $705.66M | $91.94M | $105.73M |
| 2024 | $739.62M | $101.15M | $109.67M |
| 2025 | $698.95M | $119.9M | $123.16M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CN¥6.6683)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 22 May 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.